378 On the basis of the increased activity of -gal in senescent cells, a new prodrug, SSK1, which can be specifically cleaved by lysosomal -gal into cytotoxic substances and induce the apoptosis of senescent cells, thereby eliminating senescent cells, was developed
Thus, pharmacological TRP channel targeting may offer a future possibility to attenuate paclitaxel-induced mechanical and thermal hypersensitivity in clinical practice
Frequent heavy drinking works against a recovery goal Metabolic / cellular (NAD+, MOTS-c, Glutathione) Main interaction with alcohol Alcohol metabolism draws on the same coenzymes and adds oxidative load Practical guidance Not an antidote to drinking
Pharmacokinetic evaluation of idebenone
Type 2 diabetes (formulation R2) Starting (Day 1 to 30): 1.5 mg once daily for 30 days (this dosage is not effective for glycemic control) Escalation and Maintenance Dosage: Days 31 to 60: Increase the dosage to 4 mg orally once daily Day 61 and on: If blood sugars are controlled, continue 4 mg once daily
